A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/675 (2006.01) A61K 31/66 (2006.01) A61K 31/685 (2006.01)
Patent
CA 2221416
Bisphosphonates, and particularly alendronate, can prevent or treat bone loss associated with rheumatoid arthritis.
Les bisphosphonates, et en particulier l'alendronate, peuvent prévenir ou traiter la déperdition osseuse liée à l'arthrite rhumatoïde.
Daifotis Anastasia G.
Yates Ashley J.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Bisphosphonate therapy for bone loss associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisphosphonate therapy for bone loss associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonate therapy for bone loss associated with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1867414